BioNTech AG |

Start Video March 2015

BioNTech Concepts
BioNTech Concepts
In House GMP Manufacturing
In House GMP Manufacturing
Tailored Therapy
Tailored Therapy
Potent Drugs
Potent Drugs
Serving high medical need
Serving high medical need
Immunotherapy Development
Immunotherapy Development
Selection of <br>effective drugs
Selection of
effective drugs

Welcome to Biopharmaceutical New Technologies AG!

Innovative Medicines – as Unique as You

Founded in 2008, the BioNTech Group has become one of the fastest-growing biotechnology companies in Europe. The development of fundamentally novel, cutting-edge biopharmaceuticals for treatment of many diseases with high medical need drives our success.

We are committed to serving patient needs by making medicine truly personal. Our vision is to offer precisely targeted, highly effective, and well-tolerated therapies – innovative medicines as unique as you!

Open and upcoming Clinical Trials

MERIT RNA-based cancer vaccine targeting two tumor-associated antigens (Malignant Melanoma)
IVAC MUTANOME Two RNA-based cancer vaccines targeting two tumor-associated antigens as well as tumor-specific mutations (Malignant Melanoma)
GAPVAC Actively personalized vaccination concept in newly diagnosed glioblastoma patients (Glioblastoma)
TNBC-MERIT RNA-lipoplex cancer vaccines targeting tumor-associated antigens (IVAC®WAREHOUSE) as well as tumor-specific mutations (IVAC® MUTANOME) (Triple negative breast cancer)
Lipo-MERIT RNA-lipoplex cancer vaccine targeting four tumor-associated antigens (Malignant Melanoma)

Meet BioNTech

2015 May 11-13, CIMT Meeting, Mainz, Germany

2015 May 29-June 2, ASCO, Chicago, Illinois, USA

2015 June 15-18, BIO Convention, Philadelphia, USA

.

Interested in meeting with us?
Please contact our Business Development Department
Email: ed.hc1430010815etnoi1430010815b@gni1430010815rentr1430010815ap1430010815

[TS-VCSC-Spacer height=”60″]